EPILAT-IRA Study: A contribution to the understanding of the epidemiology of acute kidney injury in Latin America
Autoři:
Raúl Lombardi aff001; Alejandro Ferreiro aff001; Rolando Claure-Del Granado aff002; Emmanuel A. Burdmann aff003; Guillermo Rosa-Diez aff004; Luis Yu aff003; Mauricio Younes-Ibrahim aff005; Cristina Carlino aff006; Jonathan S. Chávez-Iñiguez aff007; Mariana B. Pereira aff008; Carlos F. Varela aff004; Welder Zamoner aff009; Diego Janiques aff010; Soledad Lecueder aff011; Víctor Cerrón-Millán aff012; Alfonso Cueto-Manzano aff013;
Působiště autorů:
Dept. of Nephrology, School of Medicine, Universidad de la República, Montevideo, Uruguay
aff001; Division of Nephrology, Hospital Obrero #2 - C.N.S., Universidad Mayor de San Simon School of Medicine, Cochabamba, Bolivia
aff002; LIM 12, Division of Nephrology, University of Sao Paulo Medical School, Sao Paulo, Brazil
aff003; Dept. of Nehrology, Hospital Italiano, Buenos Aires, Argentina
aff004; Dept. of Internal Medicine, University of Rio de Janeiro, Rio de Janeiro, Brazil
aff005; Hospital Provincial, Rosario, Santa Fe, Argentina
aff006; Hospital Civil de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico
aff007; Nephrology Division, Hospital do Servidor Público Estadual, Universidade Nove de Julho, Sao Paulo, Brazil
aff008; Botucatu School of Medicine, São Paulo State University-UNESP, Sao Paulo, Brazil
aff009; Clinica Renalle, Pontifícia Universidade Católica, Petrópolis, Rio de Janeiro, Brazil
aff010; Sanatorio Casa de Galicia, Montevideo, Uruguay
aff011; Hospital Nacional Daniel Alcides Carrión, Dept. de Medicina, Servicio de Nefrología, Callao- Lima, Perú
aff012; Medical Research Unit of Renal Diseases, Hospital de Especialidades, CMNO, IMSS, Guadalajara, Mexico
aff013
Vyšlo v časopise:
PLoS ONE 14(11)
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0224655
Souhrn
Introduction
Epidemiology of acute kidney injury (AKI) is highly dependent on patient characteristics, context and geography. Considering the limited information in Latin America and the Caribbean, we performed a study with the aim to contribute to improve its better understanding.
Methods
Observational, prospective, longitudinal, multinational cohort study addressed to determine risk factors, clinical profile, process of care and outcomes of AKI in the region. Patients meeting KDIGO AKI definition were included over a 9-month period and designated community or hospital-acquired. De-identified clinical and lab data were entered in a specifically designed on-line platform. Co-variables potentially linked to AKI onset, in-hospital and 90-days mortality, were recorded and correlated using a multiple logistic regression model.
Results
Fifty-seven physicians from 15 countries provided data on 905 patients, most with acceptable basic needs coverage. Median age 64 (50–74) yrs; most of them were male (61%) and mestizos (42%). Comorbidities were present in 77%. AKI was community-acquired in 62%. Dehydration, shock and nephrotoxic drugs were the commonest causes. During their process of care, 77% of patients were assessed by nephrologists. Kidney replacement therapy (KRT) was performed in 29% of cases. In-hospital mortality was 26.5% and independently associated to older age, chronic liver disease, hypotension, shock, cardiac disturbances, hospital-acquired sepsis, KRT and mechanical ventilation. At 90-days follow up partial or complete renal recovery was 81% and mortality 24%.
Conclusions
AKI was mainly community-acquired, in patients with comorbidities and linked to fluid loss and nephrotoxic drugs. Mortality was high and long-term follow up poor. Notwithstanding, the study shows partially the situation in the participant countries rather than the actual epidemiology of AKI in Latin America and Caribbean, a pending and needed task.
Klíčová slova:
Death rates – Epidemiology – Kidneys – Medical dialysis – Medical risk factors – Nephrology – Nosocomial infections – Sepsis
Zdroje
1. Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA et al. Acute kidney injury: an increasing global concern. Lancet. 2013;382(9887):170–179. doi: 10.1016/S0140-6736(13)60647-9 23727171
2. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 2013;84: 457–67 doi: 10.1038/ki.2013.153 23636171
3. Mehta RL, Cerda J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 2015; 385: 2616–43. doi: 10.1016/S0140-6736(15)60126-X 25777661
4. Lombardi R, Yu L, Younes-Ibrahim M, Schor N, Burdmann E. A. Epidemiology of acute kidney injury in Latin America. Semin. Nephrol. 28, 320–329 (2008). doi: 10.1016/j.semnephrol.2008.04.001 18620955
5. KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
6. Firmat J, Zucchini A, Martin R, Aguirre C. A study of 500 cases of acute renal failure (1978–1991) Ren Fail. 1994;16:91–9. doi: 10.3109/08860229409044850 8184149
7. Vukusich A, Alvear F, Villanueva P, González C, Olivari F, Alvarado N, et al. Epidemiology of severe acute renal failure in Metropolitan Santiago Epidemiología de la Insuficiencia Renal Aguda grave. Un studio prospectivo multicéntrico en la Región Metropolitana. Rev Med Chile 2004; 132: 1355–1361 (Spanish) 15693197
8. Palomba H, do Amaral Campos PP, Corrêa TD, de Carvalho FB, Westphal G, Gusmão D, et al. Defining and treating acute kidney injury patients in Brazilian intensive care units: Results from a cross-sectional nationwide survey. J Crit Care. 2016 Aug;34:33–7. doi: 10.1016/j.jcrc.2016.03.018 27288607
9. Daher EF, Silva GB Jr, Lima RSA, Mota RMS, Rocha HAL, de Abreu KLS, et al. Different Patterns in a Cohort of Patients with Severe Leptospirosis (Weil Syndrome): Effects of an Educational Program in an Endemic Area. Am J Trop. Med Hyg, 2011. 85:479–484 doi: 10.4269/ajtmh.2011.11-0080 21896808
10. Pinho FMO, Zanetta DMT, Burdmann EA. Acute renal failure after Crotalus durissus snakebite: A prospective survey on 100 patients. Kidney Int 2005, 67:659–667 doi: 10.1111/j.1523-1755.2005.67122.x 15673314
11. Lucato RV Jr, Abdulkader RC, Barbaro KC, Mendes GE, Castro I, Baptista MA, et al. Loxosceles gaucho venom-induced acute kidney injury—in vivo and in vitro studies. PLoS Negl Trop Dis. 2011;5:e1182 doi: 10.1371/journal.pntd.0001182 21655312
12. Bezerra da Silva GB Jr, Saintrain SV, Castelo GC, de Vasconcelos VR, de Oliveira JGR, Rocha AMT, et al. Acute kidney injury in critically ill obstetric patients: a cross-sectional study in an intensive care unit in Northeast Brazil. Braz. J. Nephrol 2017;39:357–361.
13. Lombardi R, Rosa-Diez G, Ferreiro A, Greloni G, Yu L, Younes-Ibrahim M, et al; on behalf of the Acute Kidney Injury Committee of the Latin American Society of Nephrology and Hypertension (SLANH)Working Group. Acute kidney injury in Latin America: a view on renal replacement therapy resources. Nephrol Dial Transplant (2014) 29: 1369–1376 doi: 10.1093/ndt/gfu078 24744281
14. Chavez-Iñiguez JS, García-García G, Lombardi R. Epidemiología y desenlaces de la lesión renal aguda en Latinoamérica. Gac Med Mex. 2018;154(Supp 1):S6–S14. Spanish. doi: 10.24875/GMM.M18000067 30074021
15. Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet. 2016 14;387:2017–25. doi: 10.1016/S0140-6736(16)30240-9 27086173
16. Fresneda O. La medida de necesidades básicas insatisfechas (NBI) como instrumento de medición de la pobreza y focalización de programas. Serie Estudios y Perspectivas No 18, Bogotá, 2007. CEPAL, Naciones Unidas.
17. Szalachman R. Perfil de déficit y políticas de vivienda de interés social: Situación de algunos países de la región en los noventa. Serie Financiamiento del desarrollo. Santiago de Chile, 2000, CEPAL, Naciones Unidas
18. Kashani K, Macedo E, Burdmann EA, Hooi LS, Khullar D, Bagga A, et al; on behalf of the Acute Disease Quality Initiative (ADQI) Consensus Group. Acute Kidney Injury Risk Assessment: Differences and Similarities Between Resource-Limited and Resource-Rich Countries. Kidney Int Rep (2017) 2, 519–529 doi: 10.1016/j.ekir.2017.03.014 28845471
19. Lombardi R, Ferreiro A, Rosa-Diez G, Margolis A, Yu L, Younes-Ibrahim M, et al. Raising Awareness of Acute Kidney Injury: A Latin American Experience. Kidney Int Rep (2018) 3, 1416–1423 doi: 10.1016/j.ekir.2018.08.003 30450468
20. Gabriel DP, Caramori JT, Martim LC, Barretti P Balbi AL. High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Intern 2008,73: S87–S93
21. Ponce D, Buffarah MB, Goes C, Balbi A. Peritoneal Dialysis in Acute Kidney Injury: Trends in the Outcome across Time Periods. PLoS One. 2015 12;10:e0126436. doi: 10.1371/journal.pone.0126436 25965868
22. Nisula S, Kaukonen KM, Vaara ST, Korhonen AM, Poukkanen M, Karlsson S, et al; FINNAKI Study Group. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013,39:420–428 doi: 10.1007/s00134-012-2796-5 23291734
23. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 61:1627–1638
24. Holmes J, Rainer T, Geen J, Roberts G, May K, Wilson N, et al; on behalf of the Welsh AKI Steering Group. Acute Kidney Injury in the Era of the AKI E-Alert. Clin J Am Soc Nephrol 11: 2123–2131, 2016 doi: 10.2215/CJN.05170516 27793961
Článek vyšel v časopise
PLOS One
2019 Číslo 11
- Tisícileté topoly, mokří psi, stárnoucí kočky a ospalé octomilky – „jednohubky“ z výzkumu 2024/41
- Jaké jsou aktuální trendy v léčbě karcinomu slinivky?
- Menstruační krev má značný diagnostický potenciál, mimo jiné u diabetu
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul